NEURAXIS INC
NRXSNYSE AMERICAN🏆 #3980 by market capEarnings Nov 9US Equity
——
Quote unavailableTrack NRXS
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$95M
Small Cap
📈Revenue Growth (YoY)
32.9%
High Growth
📊Gross Margin
85.6%
High
💵FCF Margin
-106.0%
Thin
⚖️P/S Ratio
17.9x
Expensive
Otter Score
—
Insufficient data
No chart data available for NRXS.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $2.21 – $9.33
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 12.6M
- Next Earnings
- 2026-11-09
Fundamentals Snapshot
- Annual Revenue
- $4M
- Last Q Revenue
- $2M
- P/E Ratio
- -9.8
- P/S Ratio
- 17.9x
- EPS (TTM)
- $-0.65
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +31.3%
NEURAXIS INC
NRXSFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$4M▲ +32.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
84.2%▼ −2.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$8M▲ +9.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$6M▲ +5.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
9.1M▲ +31.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$5M▲ +$1M YoY
StockOtter · stockotter.spaceAbout NEURAXIS INC
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.